Medicine Name:
Jalra-M 50mg/500mg Tablet
Required Status:
Prescription Required
Type of Selection:
10 tablets in 1 strip
Manufacturer:
USV Ltd
Salt:
Metformin (500mg) + Vildagliptin (50mg),
MRP:
₹276.38
Uses:
Type 2 diabetes mellitus,
Alternate Medicines:
Vidaglo-M 50/500 Tablet,Ibvilda M 500 Tablet,Vibite M 500 Tablet,Vicemic-M 500 Tablet,Vilnip M 500 Tablet,
Side Effects:
Nausea,Vomiting,Diarrhea,Stomach pain,Loss of appetite,Dizziness,Headache,Trembling,Metallic taste,Hypoglycemia (low blood glucose level),
How to Use:
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Jalra-M 50mg/500mg Tablet is to be taken with food.
Chemical Class:
Not Listed
Habit Forming:
No
Therapeutic Class:
ANTI DIABETIC
Action Class:
Not Listed
. Please note, this information is for educational purposes only and not intended as medical advice.
Jalra-M 50mg/500mg Tablet: A Comprehensive Guide
When it comes to managing Type 2 diabetes mellitus, Jalra-M 50mg/500mg Tablet is a prescription medication that plays a crucial role. This medication, manufactured by USV Ltd, combines two active ingredients – Metformin (500mg) and Vildagliptin (50mg) to help regulate blood glucose levels in patients with diabetes.
Active Ingredients:
Jalra-M 50mg/500mg Tablet contains the following active ingredients:
– Metformin (500mg): Metformin is a commonly used oral medication for diabetes that helps lower blood sugar levels by decreasing glucose production in the liver and improving insulin sensitivity in the body.
– Vildagliptin (50mg): Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that helps enhance insulin secretion in response to meals, thus controlling blood glucose levels.
Pharmacological Properties:
The pharmacological properties of Jalra-M 50mg/500mg Tablet involve the synergistic action of Metformin and Vildagliptin to effectively manage blood glucose levels in patients with Type 2 diabetes mellitus. These active ingredients work by targeting different mechanisms in the body to improve insulin sensitivity and regulate blood sugar levels.
Indications:
Jalra-M 50mg/500mg Tablet is indicated for the treatment of Type 2 diabetes mellitus in patients who require medication to control their blood sugar levels. It is typically prescribed by healthcare professionals based on individual patient needs and medical history.
Contraindications:
Jalra-M 50mg/500mg Tablet is contraindicated in patients with:
– Hypersensitivity to Metformin or Vildagliptin
– Severe renal impairment
– Acute or chronic metabolic acidosis
– Type 1 diabetes mellitus
– Diabetic ketoacidosis
Dosage:
The dosage of Jalra-M 50mg/500mg Tablet should be determined by a healthcare provider based on individual patient factors such as blood glucose levels, renal function, and other medical conditions. It is important to follow the prescribed dose and administration instructions provided by the healthcare professional.
Side Effects:
Common side effects associated with Jalra-M 50mg/500mg Tablet may include:
– Nausea
– Vomiting
– Diarrhea
– Stomach pain
– Loss of appetite
– Dizziness
– Headache
– Trembling
– Metallic taste
– Hypoglycemia (low blood glucose level)
Drug Interactions:
Jalra-M 50mg/500mg Tablet may interact with other medications, supplements, or herbal products. It is important to inform the healthcare provider about all the medications being taken to avoid potential drug interactions that could affect the effectiveness or safety of Jalra-M.
Patient Counseling:
Patients taking Jalra-M 50mg/500mg Tablet should be counseled on:
– Proper administration and dosing
– Monitoring blood glucose levels regularly
– Reporting any unusual symptoms or side effects
– Following a healthy diet and exercise routine
Clinical Evidence:
Clinical studies and research support the use of Jalra-M 50mg/500mg Tablet in effectively managing blood glucose levels in patients with Type 2 diabetes mellitus. The efficacy and safety of this medication have been demonstrated in various clinical trials and real-world patient experiences.
Frequently Asked Questions (FAQs)
Q: How should I take Jalra-M 50mg/500mg Tablet?
A: Take Jalra-M 50mg/500mg Tablet as directed by your healthcare provider. Swallow it whole with food and do not chew, crush, or break the tablet.
Q: What are the common side effects of Jalra-M 50mg/500mg Tablet?
A: Common side effects may include nausea, vomiting, diarrhea, stomach pain, dizziness, and headache. If you experience any severe or persistent side effects, contact your healthcare provider.
Q: Can Jalra-M 50mg/500mg Tablet cause hypoglycemia?
A: Yes, hypoglycemia (low blood glucose levels) can occur as a side effect of Jalra-M 50mg/500mg Tablet. It is important to monitor your blood sugar levels regularly and seek medical attention if you experience symptoms of hypoglycemia.
Q: Are there any contraindications for using Jalra-M 50mg/500mg Tablet?
A: Yes, Jalra-M 50mg/500mg Tablet is contraindicated in patients with hypersensitivity to Metformin or Vildagliptin, severe renal impairment, acute or chronic metabolic acidosis, type 1 diabetes mellitus, and diabetic ketoacidosis.
Q: How long does it take for Jalra-M 50mg/500mg Tablet to show effects?
A: The onset of action of Jalra-M 50mg/500mg Tablet may vary from person to person. It is important to follow the prescribed dose and regimen to achieve optimal results in managing blood glucose levels.
Please note that the information provided here is for educational purposes only and should not be considered as medical advice. Consult a healthcare professional for personalized guidance on the use of Jalra-M 50mg/500mg Tablet and managing Type 2 diabetes mellitus.
